The payments are part of a deferred prosecution agreement under the US Foreign Corrupt Practices ... and clinics to prescribe Novartis-branded pharmaceuticals and use Alcon surgical products ...

Medical device peers Alcon, Cooper Cos. and Johnson & Johnson own 25% to 40% of the market for contact lenses vs. 10% for Bausch + Lomb. In pharmaceuticals, AbbVie would encounter antitrust ...

Regarding distributions, we view Novartis’ dividends and share repurchases as about right. Novartis has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, ...

In this article, we are going to take a look at where Novartis AG (NYSE:NVS) stands against other wonderful stocks to buy now ...

In H2 of the year so far, there are signs that the S&P 500 index has been broadening beyond technology leadership and the ...

DKSH Healthcare Business Unit, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, is excited to announce a series of initiatives across Asia in observance of ...

Signed Multiple New Business Agreements with New and Existing Customers -- -- More than Doubled Capacity with Installation of ...

Q1 2025 Earnings Call Transcript October 4, 2024 Operator: Good morning, and thank you for joining Lifecore’s Fiscal 2025 ...

Alcon Inc.’s ALC growth is driven by its ... 20.8% growth and the S&P 500 composite’s 31.2% increase. The renowned pharmaceutical and medical device manufacturer has a market capitalization ...

Cooper’s pricing power and cost optimization efforts are expected to drive margin expansion. Read why I reiterate a Buy ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

This year's award-winning companies represent a diverse range of industries including Auto (BMW), Beverages (Coca Cola Europacific Partners), Healthcare (Alcon), and Pharmaceuticals (GSK).